Pfizer Inc
- SEC CIK
- 0000078003
- Latest filing
- Aug 13, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 13, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 17
- −1 vs. Q1 2026
- Portfolio value
- $170.4M
- −$68.4M (−28.7%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SENSSenseonics Holdings, Inc. | COM | 2,171 | $12.4K | <0.1% | 00.0% | Unchanged | History |
| DNAGinkgo Bioworks Holdings, Inc. | CL A NEW | 2,928 | $30.0K | <0.1% | 00.0% | Unchanged | History |
| NXTCNextCure, Inc. | COM NEW | 44,347 | $73.0K | <0.1% | −109,007−71.1% | Reduced | History |
| BOLTBolt Biotherapeutics, Inc. | COM NEW | 31,305 | $133.8K | 0.1% | 00.0% | Unchanged | History |
| AGMBAgomAb Therapeutics NV | SPONSORED ADS | 75,000 | $1.04M | 0.6% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 538,841 | $2.88M | 1.7% | −2,300,072−81.0% | Reduced | History |
| CRDFCardiff Oncology, Inc. | COM | 2,411,575 | $3.01M | 1.8% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 372,904 | $3.55M | 2.1% | −4,407,497−92.2% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 953,834 | $3.85M | 2.3% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 2,362,348 | $5.34M | 3.1% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 4,690,431 | $7.88M | 4.6% | 00.0% | Unchanged | History |
| BHVNBiohaven Ltd. | COM | 505,645 | $8.00M | 4.7% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 1,875,000 | $10.9M | 6.4% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 7,032,770 | $19.5M | 11.4% | 00.0% | Unchanged | History |
| ARVNArvinas, Inc. | COM | 3,457,815 | $27.7M | 16.2% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 295,652 | $29.6M | 17.3% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 22,032,040 | $46.9M | 27.5% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are gone from this filing.